RXO RXO Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $22M+22.2% | $18M-30.8% | $26M+36.8% | $19M+18.8% | $16M-54.3% | ||
| $4.61B+1.5% | $4.55B0.0% | $4.55B-0.7% | $4.58B+8.0% | $4.24B+11.4% | ||
| $1.34B+1.4% | $1.32B+9.7% | $1.2B+1.4% | $1.18B-5.7% | $1.26B-6.3% | ||
| $131M-2.2% | $134M-2.2% | $137M0.0% | $137M-4.2% | $143M+5.9% | ||
| $1.11B0.0% | $1.11B-1.1% | $1.12B-0.2% | $1.13B+0.1% | $1.12B+0.1% | ||
| $442M-2.4% | $453M-2.2% | $463M-2.3% | $474M-2.1% | $484M-3.0% | ||
| $1.93B-1.4% | $1.96B-2.0% | $2B-0.8% | $2.02B-1.6% | $2.05B-1.3% | ||
| $3.27B-0.3% | $3.28B+2.4% | $3.2B0.0% | $3.2B-3.1% | $3.3B-3.2% | ||
| $2.07B+4.3% | $1.98B-1.4% | $2.01B-4.3% | $2.1B+3.9% | $2.02B+6.7% | ||
| —— | —— | —— | —— | —— | ||
| $17M0.0% | $17M+6.3% | $16M0.0% | $16M-5.9% | $17M0.0% | ||
| $1.05B+1.0% | $1.04B+14.4% | $907M+3.1% | $880M-8.7% | $964M-9.5% | ||
| $447M+10.6% | $404M+0.2% | $403M0.0% | $403M-0.2% | $404M+9.8% | ||
| $711M+1.9% | $698M-2.2% | $714M-2.6% | $733M-2.7% | $753M+2.2% | ||
| 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | 300M+14,900% | ||
| -$420M-9.4% | -$384M-13.6% | -$338M-4.3% | -$324M-2.9% | -$315M-10.9% | ||
| $1.51B-2.1% | $1.54B-2.5% | $1.58B-0.5% | $1.59B+0.1% | $1.59B-1.6% | ||
| $3.27B-0.3% | $3.28B+2.4% | $3.2B0.0% | $3.2B-3.1% | $3.3B-3.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can RXO cover its short-term obligations?
- Its current ratio is 1.27 — current assets exceed current liabilities.
- Where does RXO's balance sheet data come from?
- Every line is extracted from RXO's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.